Carmine Therapeutics
Cell & Gene Therapy
Overview
Carmine Therapeutics is pioneering a powerful new class of genetic medicines based on red blood cell extracellular vesicles (RBCEVs).
Funding and backers
Total raised
$13.7M
1 round on record
Latest round
$13.7M
Venture round · Aug 2022 · 4 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
50 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2022 | $13.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Carmine Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Donald HautExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent…
Instant Quantification of genetic modifications for Cell and Gene Therapies.
We're on a mission to fulfill the promise of genetic medicine for all patients. At Addition, we are advancing a pipeline of therapeutics to…
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
About Us We build the medicines we wish existed CPTx is a genetic medicines company redefining how we treat disease using immune-silent…
Diadem Biotherapeutics engineers first-in-class extracellular vesicles to target and treat cancer, chronic inflammatory and autoimmune…
Financials
Total raised
$13.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $13.7M | Details |
People
Donald Haut
Executive Officer, Director
Harvey Lodish
Director
Lin Xiangqian
Director
Elan Ezickson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
HQ
Contact Carmine Therapeutics
10-50 est. staff
150 CambridgePark Drive, Suite 701, Cambridge, Massachusetts 02140